Consumer Health Cancer / Oncology
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent
As Illuccix rolls out to positron emission tomography (PET) sites across the country, Mercy Radiology in Auckland became the first to administer ...
September 30, 2022 | News
Australia approved New treatment for rare cancer cholangiocarcinoma
A NEW targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Australia. PEMAZYRE® (pemigat...
September 16, 2022 | News
Merck announced that the IAP (inhibitor of apoptosis protein) inhibitor xevinapant (formerly known as Debio 1143) plus chemoradiotherapy (CRT) markedly improved long-term efficacy outcomes in patients
First randomized trial in decades to show significant improvement in overall survival in patients with LA SCCHN, reinforcing the transformative potential...
September 14, 2022 | News
SeekIn Receives CE Mark Approval for OncoSeek® Multi-Cancer Detection Test
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approva...
September 13, 2022 | News
Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive early data for two novel and investigational bispecific antibodies – uba...
September 12, 2022 | News
Merck to Highlight Data at ESMO 2022 with Potential for Transformative Impact on Cancer Patients
Late-breaking data highlight 5-year survival results from Phase II study of the investigational IAP inhibitor xevinapant in the curative setting of unres...
September 08, 2022 | News
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare inform...
September 02, 2022 | News
Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA)
lacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line...
August 21, 2022 | News
Sirnaomics Commence Treatment of Facial Squamous Cell Skin Cancer In Situ
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...
August 19, 2022 | News
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
Collaboration to accelerate the development and access of oncology medicines for cancer patients in China Clinical trial programs combining two of ...
August 05, 2022 | News
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
Research team ‘EDC’ will study ‘Extrachromosomal DNA in Cancer’. With this project, the two partners launch their ninth collabor...
August 02, 2022 | News
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging
The PSMA-PET[1] imaging agent Illuccix® from Telix Pharmaceuticals Limited (Telix) has been used in combination with the uEXPLORER®, a first-o...
July 28, 2022 | News
DS-7300 Phase 2 Trial Initiated in Patients with Pretreated Extensive-Stage Small Cell Lung Cancer
Lung cancer is the second most common cancer and the leading cause of cancer-related deaths worldwide, with up to 14% being classified as SCLC in the U.S.1...
July 22, 2022 | News
AI-based Cancer Solution Pioneer Lunit Makes Market Debut
Lunit expects to raise approximately KRW 36.4 billion (US$ 28 million). Lunit intends to use the proceeds for R&D of its new AI products and ...
July 22, 2022 | News
Most Read
- Hidden Pollution: Asia’s Rivers are Teeming with Pharmaceuticals
- Gibco Freedom ExpiCHO-S Cell Line Development Kit
- Samsung Biologics , AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy
- Honeywell Solstice Propellant Receives NMPA Registration for China New Cosmetic Raw Materials
- HKU microbiology researchers collaborating with vaccine manufacturers
- GenScript ProBio To Expands It's Manufacturing Capacity in China
- Scientists discover and name novel gene that governs left-right asymmetry within the human body
- Yokogawa developed the Single Cellome system SS2000 for subcellular sampling
Bio Jobs
- Step-by-step breakdown: How to write a strong resume
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Find your Job at Eppendorf
- Thermo Fisher Scientific - Singapore is hiring for Account Manager | Apply Now!
- Healthcare and Technology to remain key recruiting sectors for India's recovery in 2021
News
Editor Picks
